Interleukin 1, interleukin 6, interleukin 10, and tumor necrosis factor α in active and quiescent systemic lupus erythematosus

Journal of Investigative Medicine

Volumn 62, Issue 5, 2014, Pages 825-829

  Cigni, Alessandro ^a   Pileri, Piera Veronica ^a   Faedda, Rossana ^a   Gallo, Paola ^a   Sini, Annalisa ^a   Satta, Andrea Ercole ^a   Marras, Riccardo ^a   Carta, Elisabetta ^a   Argiolas, Davide ^a   Rum, Iolanda ^a   Masala, Antonio ^a  

^a UNIVERSITY OF SASSARI   (Italy)

Author keywords

Interleukin 1; Interleukin 11; Interleukin 6; Systemic lupus erythematosus; Tumor necrosis factor

Indexed keywords

AZATHIOPRINE; C REACTIVE PROTEIN; CYCLOPHOSPHAMIDE; CYCLOSPORIN A; HYDROXYCHLOROQUINE; INTERLEUKIN 1; INTERLEUKIN 10; INTERLEUKIN 6; METHYLPREDNISOLONE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISONE; TRIPTORELIN; TUMOR NECROSIS FACTOR ALPHA; BIOLOGICAL MARKER; IL10 PROTEIN, HUMAN; IL6 PROTEIN, HUMAN;

ADD ON THERAPY; ADULT; ARTICLE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DISEASE ACTIVITY; DRUG DOSE REDUCTION; FEMALE; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LUPUS ERYTHEMATOSUS NEPHRITIS; MAJOR CLINICAL STUDY; OVARY INSUFFICIENCY; PROTEIN BLOOD LEVEL; REMISSION; SLEDAI; SYSTEMIC LUPUS ERYTHEMATOSUS; BLOOD; COHORT ANALYSIS; ITALY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED;

ADULT; BIOLOGICAL MARKERS; COHORT STUDIES; FEMALE; HUMANS; INTERLEUKIN-1; INTERLEUKIN-10; INTERLEUKIN-6; ITALY; LUPUS ERYTHEMATOSUS, SYSTEMIC; MIDDLE AGED; TUMOR NECROSIS FACTOR-ALPHA;

EID: 84902174660     PISSN: 17088267     EISSN: 17088267     Source Type: Journal    
DOI: 10.2310/JIM.0000000000000085     Document Type: Article

References (17)

1. Kotzin BL. Systemic lupus erythematosus. Cell. 1996;85:303-306. (Pubitemid 26160701)
2. Dean GS, Tyrrell-Price J, Crawley E, et al. Cytokines and systemic lupus erythematosus. Ann Rheum Dis. 2000;59:243-251. (Pubitemid 30305564)
3. Mok CC, Lau CS. Pathogenesis of systemic lupus erythematosus. J Clin Pathol. 2003;56:481-490. (Pubitemid 36819418)
4. Sabry A, Sheashaa H, El-Husseini A, et al. Proinflammatory cytokines (TNF-alpha and IL-6) in Egyptian patients with SLE: its correlation with disease activity. Cytokine. 2006;35:148-153. (Pubitemid 44666430)
5. Illei GG, Tackey E, Lapteva L, et al. Biomarkers in systemic lupus erythematosus. II. Markers of disease activity. Arthritis Rheum. 2004;50:2048-2065. (Pubitemid 38924382)
6. Chun HY, Chung JW, Kim HA, et al. Cytokine IL-6 and IL-10 as biomarkers in systemic lupus erythematosus. J Clin Immunol. 2007;27:461-466.
7. Tan EM, Cohen AS, Fries JI, et al. The 1982 revised criteria for the classification of systemic lupus erythematosus. Arthritis Rheum. 1982;25:1271-1277. (Pubitemid 13221242)
8. Bombardier C, Gladman DD, Urowitz MB, et al. Derivation of the SLEDAI. A disease activity index for lupus patients. The committee on prognosis studies in SLE. Arthritis Rheum. 1992;35:630-640.
9. Faedda R, Palomba D, Satta A, et al. Immunosuppressive treatment of the glomerulonephritis of the systemic lupus. Clin Nephrol. 1995;44: 367-375. (Pubitemid 26002815)
10. Cigni A, Faedda R, Atzeni MM, et al. Hormonal strategies for fertility preservation in patients receiving cyclophosphamide to treat glomerulonephritis: a nonrandomized trial and review of the literature. Am J Kidney Dis. 2008;52:887-896.
11. Weening JJ, D'Agati VD, Schwartz MM, et al. Classification of glomerulonephritis in systemic lupus erythematosus revisited. Kidney Int. 2004;65:521-530. (Pubitemid 38130646)
12. Cordeiro AC, Isenberg DA. Novel therapies in lupusVfocus on nephritis. Acta Reumatol Port. 2008;33:157-169.
13. Liou LB. Serum and in vitro production of IL-1 receptor antagonist correlate with C-reactive protein levels in newly diagnosed, untreated lupus patients. Clin Exp Rheumatol. 2001;19:515-523.
14. Tackey E, Lipsky PE, Illei GG. Rationale for interleukin-6 blockade in systemic lupus erythematosus. Lupus. 2004;13:339-343. (Pubitemid 38788493)
15. Gomez D, Correa PA, Gomez LM, et al. Th1/Th2 cytokines in patients with systemic lupus erythematosus: is tumor necrosis factor alpha protective? Semin Arthritis Rheum. 2004;33:404-413.
16. Smolen JS, Steiner G, Aringer M. Anti-cytokine therapy in systemic lupus erythematosus. Lupus. 2005;14:189-191. (Pubitemid 40445581)
17. Aringer M, Smolen JS. Cytokine expression in lupus kidneys. Lupus. 2005;14:13-18. (Pubitemid 40216062)